3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
26
Colonic Neoplasms
11
Rectal Neoplasms
10
Colorectal Neoplasms
10
Carcinoma, Non-Small-Cell Lung
9
Uterine Cervical Neoplasms
8
Neoplasms
8
Lung Neoplasms
7
Endometrial Neoplasms
7
Small Cell Lung Carcinoma
6
Prostatic Neoplasms
6
Depression
6
Tobacco Use Disorder
5
Leukemia, Myeloid, Acute
5
Anxiety Disorders
5
Pancreatic Neoplasms
4
Carcinoma, Intraductal, Noninfiltrating
4
Breast Carcinoma In Situ
4
Urinary Bladder Neoplasms
3
Stomach Neoplasms
3
Sexuality
3
Sexual Dysfunction, Physiological
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Overweight
3
Ovarian Neoplasms
3
Obesity
3
Leukemia
3
Fatigue
3
Esophageal Neoplasms
3
Carcinoma, Renal Cell
3
Interventions
Paclitaxel
6
Carboplatin
6
Radiotherapy
5
Chemotherapy, Adjuvant
5
Cyclophosphamide
4
Trastuzumab
3
Tamoxifen
3
Letrozole
3
Doxorubicin
3
Brachytherapy
3
Albumin-Bound Paclitaxel
3
130-nm albumin-bound paclitaxel
3
pertuzumab
2
Surgical Procedures, Operative
2
Radiotherapy, Conformal
2
Magnetic Resonance Spectroscopy
2
Epirubicin
2
talimogene laherparepvec
1
sargramostim
1
palbociclib
1
ferric carboxymaltose
1
atezolizumab
1
atamestane
1
aldesleukin
1
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
1
VPS Coriolus versicolor extract
1
Toremifene
1
Thiotepa
1
Therapeutics
1
Reverse Transcriptase Polymerase Chain Reaction
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Carcinoma, Ductal, Breast
×
Counseling
×
Clear all
NCT01819233
2025-06-06
CAREFOR
Thomas Jefferson University
Phase NA
Completed
38 enrolled
10 charts